Dr Fowler argued that the 13 July 1983 CSM(B) recommendation implied that 'pre-March 83' material should be used until adequate supplies of 'post-March 83' material were available.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr L K Fowler